Blood stem cells are vulnerable to DNA damage that can persist for several years, according to a new UK study which casts new light on the origins of blood cancers.
A team led by researchers at the Wellcome Sanger Institute, Cambridge, say this ar...
17 days ago
A drug being tested for breast cancer might help to block the progression of myeloproliferative neoplasms, and possibly become a treatment for acute myeloid leukaemia, researchers have reported.
Scientists studied the impact of inhibiting the prot...
17 days ago